CLINICAL_TRIALS
research
· 2026-03-04
Clinical Trial Update: A Privacy-Preserving OCR-LLM System for Coronary Syndrome Subtyping From Admission HPI: Multicenter Validation in China and the US
Summary
This clinical trial update describes a privacy-preserving OCR-LLM system for subtyping coronary syndromes from admission histories, with multicenter validation …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Acute Coronary Syndromes | Status: NOT_YET_RECRUITING